Skip to main navigation Skip to search Skip to main content

Safety and activity of docetaxel and trastuzumab in HER2 overexpressing metastatic breast cancer. a pilot phase II study

  • MONTEMURRO FILIPPO
  • , CHOA GABRIELLA
  • , FAGGIUOLO ROBERTO
  • , CAPALDI ANTONIO
  • , SAROTTO IVANA
  • , DE ROSA GIOVANNI
  • , DONADIO MICHELA
  • , MINISCHETTI MONICA
  • , SALOMONE ATTILIO
  • , VIETTI RAMUS GUIDO
  • , ALABISO Oscar
  • , AGLIETTA MASSIMO

Research output: Contribution to conferencePaper

Original languageEnglish
Publication statusPublished - 1 Jan 2002
Externally publishedYes
EventProc Am Soc Clin Oncol -
Duration: 1 Jan 2003 → …

Conference

ConferenceProc Am Soc Clin Oncol
Period1/01/03 → …

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this